Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
39 participants
OBSERVATIONAL
2017-05-01
2017-11-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To document and better define the prognostic characteristics of residual disability 12 months or more following an ischaemic stroke in patients that originally participated in the preceding clinical study RN-CS-0001.
Other objective:
To inform the design of efficient Phase 2/3 studies when screening potentially efficacious interventions for signals of activity which merit further development.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participation in the preceding study RN-CS-0001
* Completion of at least one of the 4 functional assessment tests (ARAT, BI, NIHSS, mRS) at any time point on the previous study RN-CS-0001
* Ability to participate in all assessments and attend all visits
Exclusion Criteria
* Incidence of significant other disease that judged by the investigator would confound completion of all functional assessments (not excluding patients that can complete at least one functional assessment with no confounding factor from significant other disease).
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ReNeuron Limited
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New Queen Elizabeth Hospital
Birmingham, , United Kingdom
Ninewells Hospital & Medical School
Dundee, , United Kingdom
Queen Elizabeth University Hospital.
Glasgow, , United Kingdom
University College London Hospital Stroke Research Centre
London, , United Kingdom
The University of Manchester Institute of Cardiovascular Research
Manchester, , United Kingdom
Nottingham City Hospital
Nottingham, , United Kingdom
University Hospital Southampton NHS Foundation Trust
Southampton, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RN-CS-0002
Identifier Type: -
Identifier Source: org_study_id